Elderberry targets the same enzyme as Tamiflu and nobody puts that on the label episode artwork

EPISODE · Apr 20, 2026 · 5 MIN

Elderberry targets the same enzyme as Tamiflu and nobody puts that on the label

from NutraSift: The nutraceutical innovation podcast · host Siftlink SA

Elderberry cyanidin glycosides inhibit viral neuraminidase the same mechanism as oseltamivir (Tamiflu). That's a specific, defined, anti-viral target. But the industry markets elderberry as generic "immune support" because regulators won't allow anti-viral claims on a food supplement. The mechanism is there. The IP is there. The claim structure isn't.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/23748498/https://pubmed.ncbi.nlm.nih.gov/19682714/https://pubmed.ncbi.nlm.nih.gov/29199545/

Episode metadata supplied by the publisher feed · Published Apr 20, 2026

Embed this episode

NOW PLAYING

Elderberry targets the same enzyme as Tamiflu and nobody puts that on the label

0:00 5:01

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NutraSift: The nutraceutical innovation podcast?

This episode is 5 minutes long.

When was this NutraSift: The nutraceutical innovation podcast episode published?

This episode was published on April 20, 2026.

Can I download this NutraSift: The nutraceutical innovation podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!